Abstract

Etoricoxib is an oral nonsteroidal anti-inflammatory drug (NSAID). It acts as a selective cyclo-oxygenase-2 (COX-2) inhibitor with anti-inflammatory, analgesic and antipyretic properties. Etoricoxib is available as a tablet formulation in strengths of 60 mg, 90 mg or 120 mg.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call